Any significant change from baselineparticularly the development of bloody stools, nocturnal diarrhea awakening them from sleep, or progressive worsening of symptomswarrants prompt clinical assessment
"However, if symptoms persist or worsen, it may be necessary to discontinue the medication." But if this is more about skin changes, Goldenberg says it's crucial to focus on internal and external hydrationmeaning, drink plenty of water and grab an unscented moisturizer
Conclusion Monitoring your progress with GLP-1 therapy isnt just about watching the scale
Neither route is automatically better for everyone
In conclusion, liraglutide (Saxenda) is approved for adults with a BMI of 30 kg/m2 or greater, or a BMI of 27 kg/m2 or greater with at least one weight-related condition, as an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management
Ryu GR, Lee E, Chun HJ, Yoon KH, Ko SH, Ahn YB, et al